1. Home
  2. AHG vs MGTX Comparison

AHG vs MGTX Comparison

Compare AHG & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AHG
  • MGTX
  • Stock Information
  • Founded
  • AHG 2013
  • MGTX 2015
  • Country
  • AHG China
  • MGTX United States
  • Employees
  • AHG N/A
  • MGTX N/A
  • Industry
  • AHG Business Services
  • MGTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • AHG Consumer Discretionary
  • MGTX Health Care
  • Exchange
  • AHG Nasdaq
  • MGTX Nasdaq
  • Market Cap
  • AHG 752.4M
  • MGTX 744.9M
  • IPO Year
  • AHG N/A
  • MGTX N/A
  • Fundamental
  • Price
  • AHG $1.51
  • MGTX $7.55
  • Analyst Decision
  • AHG
  • MGTX Strong Buy
  • Analyst Count
  • AHG 0
  • MGTX 6
  • Target Price
  • AHG N/A
  • MGTX $23.83
  • AVG Volume (30 Days)
  • AHG 10.4K
  • MGTX 552.4K
  • Earning Date
  • AHG 12-15-2025
  • MGTX 11-13-2025
  • Dividend Yield
  • AHG N/A
  • MGTX N/A
  • EPS Growth
  • AHG N/A
  • MGTX N/A
  • EPS
  • AHG N/A
  • MGTX N/A
  • Revenue
  • AHG $14,777,798.00
  • MGTX $27,417,000.00
  • Revenue This Year
  • AHG N/A
  • MGTX $110.63
  • Revenue Next Year
  • AHG N/A
  • MGTX $212.13
  • P/E Ratio
  • AHG N/A
  • MGTX N/A
  • Revenue Growth
  • AHG 512.09
  • MGTX 96.83
  • 52 Week Low
  • AHG $0.74
  • MGTX $4.55
  • 52 Week High
  • AHG $2.35
  • MGTX $9.73
  • Technical
  • Relative Strength Index (RSI)
  • AHG 45.04
  • MGTX 37.64
  • Support Level
  • AHG $1.33
  • MGTX $7.30
  • Resistance Level
  • AHG $1.56
  • MGTX $7.94
  • Average True Range (ATR)
  • AHG 0.09
  • MGTX 0.67
  • MACD
  • AHG 0.00
  • MGTX -0.14
  • Stochastic Oscillator
  • AHG 35.94
  • MGTX 10.70

About AHG Akso Health Group ADS

Akso Health Group is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.

Share on Social Networks: